Bruker (BRKR) Research & Development (2010 - 2026)

Bruker (BRKR) has reported Research & Development for 17 consecutive years, with $94.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 5.89% year-over-year to $94.3 million; the trailing twelve-month figure through Jun 2026 stood at $393.5 million (down 1.58% YoY), and the FY2025 full-year result was $395.2 million, up 4.97% from the prior year.
• Research & Development fell to $94.3 million in Q2 2026 per BRKR's latest filing, from $101.3 million in the prior quarter.
• Across five years, Research & Development topped out at $104.4 million in Q4 2024 and bottomed at $56.2 million in Q3 2022.
• Historically, Research & Development has averaged $83.2 million across 5 years, with a median of $87.8 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Research & Development jumped 37.59% in 2024, then retreated 5.89% in 2026.
• Over 5 years, Research & Development stood at $63.5 million in 2022, then jumped by 31.5% to $83.5 million in 2023, then increased by 25.03% to $104.4 million in 2024, then decreased by 4.6% to $99.6 million in 2025, then dropped by 5.32% to $94.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $94.3 million, $101.3 million, and $99.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.